Overview

Different β -Blockers in STEMI and Primary PCI

Status:
Not yet recruiting

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

Carvedilol, target dose: 50 mg daily; Bisoprolol, target dose: 10 mg daily; Metoprolol tartrate, target dose: 150 mg daily; Metroprolol succinate, target dose: 200 mg daily

Phase:

N/A

Details

Lead Sponsor:

Qilu Hospital of Shandong University

Treatments:

Adrenergic beta-Antagonists
Bisoprolol
Metoprolol